2gpv › Citations

X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation.

Wang L, Zuercher WJ, Consler TG, Lambert MH, Miller AB, Orband-Miller LA, McKee DD, Willson TM, Nolte RT
J Biol Chem 281 37773-81 (2006)
Related entries: 2gp7, 2gpo, 2gpp, 2gpu

Cited: 67 times
EuropePMC logo PMID: 16990259

Abstract

X-ray crystal structures of the ligand binding domain (LBD) of the estrogen-related receptor-gamma (ERRgamma) were determined that describe this receptor in three distinct states: unliganded, inverse agonist bound, and agonist bound. Two structures were solved for the unliganded state, the ERRgamma LBD alone, and in complex with a coregulator peptide representing a portion of receptor interacting protein 140 (RIP140). No significant differences were seen between these structures that both exhibited the conformation of ERRgamma seen in studies with other coactivators. Two structures were obtained describing the inverse agonist-bound state, the ERRgamma LBD with 4-hydroxytamoxifen (4-OHT), and the ERRgamma LBD with 4-OHT and a peptide representing a portion of the silencing mediator of retinoid and thyroid hormone action protein (SMRT). The 4-OHT structure was similar to other reported inverse agonist bound structures, showing reorientation of phenylalanine 435 and a displacement of the AF-2 helix relative to the unliganded structures with little other rearrangement occurring. No significant changes to the LBD appear to be induced by peptide binding with the addition of the SMRT peptide to the ERRgamma plus 4-OHT complex. The observed agonist-bound state contains the ERRgamma LBD, a ligand (GSK4716), and the RIP140 peptide and reveals an unexpected rearrangement of the phenol-binding residues. Thermal stability studies show that agonist binding leads to global stabilization of the ligand binding domain. In contrast to the conventional mechanism of nuclear receptor ligand activation, activation of ERRgamma by GSK4716 does not appear to involve a major rearrangement or significant stabilization of the C-terminal helix.

Articles - 2gpv mentioned but not cited (5)

  1. Structure of Rev-erbalpha bound to N-CoR reveals a unique mechanism of nuclear receptor-co-repressor interaction. Phelan CA, Gampe RT, Lambert MH, Parks DJ, Montana V, Bynum J, Broderick TM, Hu X, Williams SP, Nolte RT, Lazar MA. Nat Struct Mol Biol 17 808-814 (2010)
  2. Nuclear receptor full-length architectures: confronting myth and illusion with high resolution. Rastinejad F, Ollendorff V, Polikarpov I. Trends Biochem Sci 40 16-24 (2015)
  3. Selectively targeting prostate cancer with antiandrogen equipped histone deacetylase inhibitors. Gryder BE, Akbashev MJ, Rood MK, Raftery ED, Meyers WM, Dillard P, Khan S, Oyelere AK. ACS Chem Biol 8 2550-2560 (2013)
  4. Modulating protein-protein interactions with small molecules: the importance of binding hotspots. Thangudu RR, Bryant SH, Panchenko AR, Madej T. J Mol Biol 415 443-453 (2012)
  5. Evaluation of the Therapeutic Effect of the Traditional Herbal Medicine Atrifil and Oshagh Gum on Testosterone-Induced Benign Prostatic Hyperplasia in Wistar Rats. Akbari F, Azadbakht M, Gaurav A, Azimi F, Mahdizadeh Z, Vahedi L, Barzegar Nejad A, Chabra A, Eghbali M. Adv Urol 2022 5742431 (2022)


Reviews citing this publication (16)

  1. Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond. Deblois G, Giguère V. Nat Rev Cancer 13 27-36 (2013)
  2. Design of selective nuclear receptor modulators: RAR and RXR as a case study. de Lera AR, Bourguet W, Altucci L, Gronemeyer H. Nat Rev Drug Discov 6 811-820 (2007)
  3. Nuclear hormone receptor co-repressors: structure and function. Watson PJ, Fairall L, Schwabe JW. Mol Cell Endocrinol 348 440-449 (2012)
  4. The NR3B subgroup: an ovERRview. Tremblay AM, Giguère V. Nucl Recept Signal 5 e009 (2007)
  5. Stabilization of protein-protein interactions in drug discovery. Andrei SA, Sijbesma E, Hann M, Davis J, O'Mahony G, Perry MWD, Karawajczyk A, Eickhoff J, Brunsveld L, Doveston RG, Milroy LG, Ottmann C. Expert Opin Drug Discov 12 925-940 (2017)
  6. An evolving understanding of nuclear receptor coregulator proteins. Millard CJ, Watson PJ, Fairall L, Schwabe JW. J Mol Endocrinol 51 T23-36 (2013)
  7. A structural view of nuclear hormone receptor: endocrine disruptor interactions. le Maire A, Bourguet W, Balaguer P. Cell Mol Life Sci 67 1219-1237 (2010)
  8. Esrrb, an estrogen-related receptor involved in early development, pluripotency, and reprogramming. Festuccia N, Owens N, Navarro P. FEBS Lett 592 852-877 (2018)
  9. Orphan nuclear receptors as targets for drug development. Mukherjee S, Mani S. Pharm Res 27 1439-1468 (2010)
  10. Estrogen-related receptor β (ERRβ) - renaissance receptor or receptor renaissance? Divekar SD, Tiek DM, Fernandez A, Riggins RB. Nucl Recept Signal 14 e002 (2016)
  11. Lipoprotein Drug Delivery Vehicles for Cancer: Rationale and Reason. Chaudhary J, Bower J, Corbin IR. Int J Mol Sci 20 E6327 (2019)
  12. The PGC-1/ERR network and its role in precision oncology. De Vitto H, Bode AM, Dong Z. NPJ Precis Oncol 3 9 (2019)
  13. The emerging role of estrogen related receptorα in complications of non-small cell lung cancers. Mukherjee TK, Malik P, Hoidal JR. Oncol Lett 21 258 (2021)
  14. Milk Exosomal microRNAs: Postnatal Promoters of β Cell Proliferation but Potential Inducers of β Cell De-Differentiation in Adult Life. Melnik BC, Schmitz G. Int J Mol Sci 23 11503 (2022)
  15. International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023. Burris TP, de Vera IMS, Cote I, Flaveny CA, Wanninayake US, Chatterjee A, Walker JK, Steinauer N, Zhang J, Coons LA, Korach KS, Cain DW, Hollenberg AN, Webb P, Forrest D, Jetten AM, Edwards DP, Grimm SL, Hartig S, Lange CA, Richer JK, Sartorius CA, Tetel M, Billon C, Elgendy B, Hegazy L, Griffett K, Peinetti N, Burnstein KL, Hughes TS, Sitaula S, Stayrook KR, Culver A, Murray MH, Finck BN, Cidlowski JA. Pharmacol Rev 75 1233-1318 (2023)
  16. [Academic Detailing from the Viewpoint of Chemical Structural Formulas]. Wada T. Yakugaku Zasshi 139 1101-1105 (2019)

Articles citing this publication (46)

  1. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Raghuram S, Stayrook KR, Huang P, Rogers PM, Nosie AK, McClure DB, Burris LL, Khorasanizadeh S, Burris TP, Rastinejad F. Nat Struct Mol Biol 14 1207-1213 (2007)
  2. Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor. Andersen RJ, Mawji NR, Wang J, Wang G, Haile S, Myung JK, Watt K, Tam T, Yang YC, Bañuelos CA, Williams DE, McEwan IJ, Wang Y, Sadar MD. Cancer Cell 17 535-546 (2010)
  3. Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma. Okada H, Tokunaga T, Liu X, Takayanagi S, Matsushima A, Shimohigashi Y. Environ Health Perspect 116 32-38 (2008)
  4. Estrogen-related receptor gamma is a key regulator of muscle mitochondrial activity and oxidative capacity. Rangwala SM, Wang X, Calvo JA, Lindsley L, Zhang Y, Deyneko G, Beaulieu V, Gao J, Turner G, Markovits J. J Biol Chem 285 22619-22629 (2010)
  5. Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors. Ao A, Wang H, Kamarajugadda S, Lu J. Proc Natl Acad Sci U S A 105 7821-7826 (2008)
  6. Orphan nuclear receptor estrogen-related receptor γ (ERRγ) is key regulator of hepatic gluconeogenesis. Kim DK, Ryu D, Koh M, Lee MW, Lim D, Kim MJ, Kim YH, Cho WJ, Lee CH, Park SB, Koo SH, Choi HS. J Biol Chem 287 21628-21639 (2012)
  7. A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor. le Maire A, Teyssier C, Erb C, Grimaldi M, Alvarez S, de Lera AR, Balaguer P, Gronemeyer H, Royer CA, Germain P, Bourguet W. Nat Struct Mol Biol 17 801-807 (2010)
  8. Phosphorylation-dependent sumoylation regulates estrogen-related receptor-alpha and -gamma transcriptional activity through a synergy control motif. Tremblay AM, Wilson BJ, Yang XJ, Giguère V. Mol Endocrinol 22 570-584 (2008)
  9. ERRgamma tethers strongly bisphenol A and 4-alpha-cumylphenol in an induced-fit manner. Matsushima A, Teramoto T, Okada H, Liu X, Tokunaga T, Kakuta Y, Shimohigashi Y. Biochem Biophys Res Commun 373 408-413 (2008)
  10. Estrogen-Related Receptors Mediate the Adaptive Response of Brown Adipose Tissue to Adrenergic Stimulation. Brown EL, Hazen BC, Eury E, Wattez JS, Gantner ML, Albert V, Chau S, Sanchez-Alavez M, Conti B, Kralli A. iScience 2 221-237 (2018)
  11. The significance of the expression of ERRalpha as a potential biomarker in breast cancer. Jarzabek K, Koda M, Kozlowski L, Sulkowski S, Kottler ML, Wolczynski S. J Steroid Biochem Mol Biol 113 127-133 (2009)
  12. Ligand dissociation from estrogen receptor is mediated by receptor dimerization: evidence from molecular dynamics simulations. Sonoda MT, Martínez L, Webb P, Skaf MS, Polikarpov I. Mol Endocrinol 22 1565-1578 (2008)
  13. Structural basis for retinoic X receptor repression on the tetramer. Zhang H, Chen L, Chen J, Jiang H, Shen X. J Biol Chem 286 24593-24598 (2011)
  14. Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers. Minges JT, Su S, Grossman G, Blackwelder AJ, Pop EA, Mohler JL, Wilson EM. J Biol Chem 288 1939-1952 (2013)
  15. Esrrg functions in early branch generation of the ureteric bud and is essential for normal development of the renal papilla. Berry R, Harewood L, Pei L, Fisher M, Brownstein D, Ross A, Alaynick WA, Moss J, Hastie ND, Hohenstein P, Davies JA, Evans RM, FitzPatrick DR. Hum Mol Genet 20 917-926 (2011)
  16. Distinct mechanisms of endocrine disruption of DDT-related pesticides toward estrogen receptor α and estrogen-related receptor γ. Zhuang S, Zhang J, Wen Y, Zhang C, Liu W. Environ Toxicol Chem 31 2597-2605 (2012)
  17. Estrogen induces estrogen-related receptor alpha gene expression and chromatin structural changes in estrogen receptor (ER)-positive and ER-negative breast cancer cells. Hu P, Kinyamu HK, Wang L, Martin J, Archer TK, Teng C. J Biol Chem 283 6752-6763 (2008)
  18. Inverse antagonist activities of parabens on human oestrogen-related receptor γ (ERRγ): in vitro and in silico studies. Zhang Z, Sun L, Hu Y, Jiao J, Hu J. Toxicol Appl Pharmacol 270 16-22 (2013)
  19. A molecular switch regulating transcriptional repression and activation of PPARγ. Shang J, Mosure SA, Zheng J, Brust R, Bass J, Nichols A, Solt LA, Griffin PR, Kojetin DJ. Nat Commun 11 956 (2020)
  20. Distinction of the binding modes for human nuclear receptor ERRgamma between bisphenol A and 4-hydroxytamoxifen. Liu X, Matsushima A, Okada H, Shimohigashi Y. J Biochem 148 247-254 (2010)
  21. ERRβ splice variants differentially regulate cell cycle progression. Heckler MM, Riggins RB. Cell Cycle 14 31-45 (2015)
  22. Estrogen-related receptor γ serves a role in blood pressure homeostasis during pregnancy. Luo Y, Kumar P, Chen CC, Latham J, Wang L, Tudela C, Alexander JM, Shelton JM, McKown L, Mendelson CR. Mol Endocrinol 28 965-975 (2014)
  23. On the intractability of estrogen-related receptor alpha as a target for activation by small molecules. Hyatt SM, Lockamy EL, Stein RA, McDonnell DP, Miller AB, Orband-Miller LA, Willson TM, Zuercher WJ. J Med Chem 50 6722-6724 (2007)
  24. Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ. Heidari Z, Chrisman IM, Nemetchek MD, Novick SJ, Blayo AL, Patton T, Mendes DE, Diaz P, Kamenecka TM, Griffin PR, Hughes TS. Nat Commun 10 5825 (2019)
  25. Binding mode prediction and MD/MMPBSA-based free energy ranking for agonists of REV-ERBα/NCoR. Westermaier Y, Ruiz-Carmona S, Theret I, Perron-Sierra F, Poissonnet G, Dacquet C, Boutin JA, Ducrot P, Barril X. J Comput Aided Mol Des 31 755-775 (2017)
  26. Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer. Heckler MM, Zeleke TZ, Divekar SD, Fernandez AI, Tiek DM, Woodrick J, Farzanegan A, Roy R, Üren A, Mueller SC, Riggins RB. Oncotarget 7 47201-47220 (2016)
  27. Cartilage-specific overexpression of ERRγ results in Chondrodysplasia and reduced chondrocyte proliferation. Cardelli M, Zirngibl RA, Boetto JF, McKenzie KP, Troy TC, Turksen K, Aubin JE. PLoS One 8 e81511 (2013)
  28. Divergent regulation of the Osteopontin promoter by the estrogen receptor-related receptors is isoform- and cell context dependent. Zirngibl RA, Chan JS, Aubin JE. J Cell Biochem 114 2356-2362 (2013)
  29. Structural insights into Estrogen Related Receptor-β modulation: 4-methylenesterols from Theonella swinhoei sponge as the first example of marine natural antagonists. Di Micco S, Renga B, Carino A, D'Auria MV, Zampella A, Riccio R, Fiorucci S, Bifulco G. Steroids 80 51-63 (2014)
  30. Identification of novel inverse agonists of estrogen-related receptors ERRγ and ERRβ. Yu DD, Huss JM, Li H, Forman BM. Bioorg Med Chem 25 1585-1599 (2017)
  31. Importance of the Sequence-Directed DNA Shape for Specific Binding Site Recognition by the Estrogen-Related Receptor. Mohideen-Abdul K, Tazibt K, Bourguet M, Hazemann I, Lebars I, Takacs M, Cianférani S, Klaholz BP, Moras D, Billas IML. Front Endocrinol (Lausanne) 8 140 (2017)
  32. A Novel ESRRB Deletion Is a Rare Cause of Autosomal Recessive Nonsyndromic Hearing Impairment among Pakistani Families. Lee K, Khan S, Ansar M, Santos-Cortez RL, Ahmad W, Leal SM. Genet Res Int 2011 368915 (2011)
  33. A characteristic back support structure in the bisphenol A-binding pocket in the human nuclear receptor ERRγ. Liu X, Matsushima A, Shimohigashi M, Shimohigashi Y. PLoS One 9 e101252 (2014)
  34. Ternary crystal structure of human RORγ ligand-binding-domain, an inhibitor and corepressor peptide provides a new insight into corepressor interaction. Noguchi M, Nomura A, Doi S, Yamaguchi K, Hirata K, Shiozaki M, Maeda K, Hirashima S, Kotoku M, Yamaguchi T, Katsuda Y, Crowe P, Tao H, Thacher S, Adachi T. Sci Rep 8 17374 (2018)
  35. 1-Benzyl-4-phenyl-1H-1,2,3-triazoles improve the transcriptional functions of estrogen-related receptor γ and promote the browning of white adipose. Xu S, Mao L, Ding P, Zhuang X, Zhou Y, Yu L, Liu Y, Nie T, Xu T, Xu Y, Liu J, Smaill J, Ren X, Wu D, Ding K. Bioorg Med Chem 23 3751-3760 (2015)
  36. Orphan nuclear receptor ERRγ is a key regulator of human fibrinogen gene expression. Zhang Y, Kim DK, Lu Y, Jung YS, Lee JM, Kim YH, Lee YS, Kim J, Dewidar B, Jeong WI, Lee IK, Cho SJ, Dooley S, Lee CH, Li X, Choi HS. PLoS One 12 e0182141 (2017)
  37. Computer-aided design and synthesis of tetra-aryl-substituted alkenes and their bioevaluation as a selective modulator of estrogen-related receptor γ. Koh M, Park SB. Mol Divers 15 69-81 (2011)
  38. Design, synthesis, and evaluation of simple phenol amides as ERRγ agonists. Lin H, Doebelin C, Patouret R, Garcia-Ordonez RD, Chang MR, Dharmarajan V, Bayona CR, Cameron MD, Griffin PR, Kamenecka TM. Bioorg Med Chem Lett 28 1313-1319 (2018)
  39. Effects of the hydroxyl group on phenyl based ligand/ERRγ protein binding. Starovoytov ON, Liu Y, Tan L, Yang S. Chem Res Toxicol 27 1371-1379 (2014)
  40. Modulation of estrogen-related receptors subtype selectivity: Conversion of an ERRβ/γ selective agonist to ERRα/β/γ pan agonists. Shahien M, Elagawany M, Sitaula S, Goher SS, Burris SL, Sanders R, Avdagic A, Billon C, Hegazy L, Burris TP, Elgendy B. Bioorg Chem 102 104079 (2020)
  41. An Inverse Agonist GSK5182 Increases Protein Stability of the Orphan Nuclear Receptor ERRγ via Inhibition of Ubiquitination. Na SY, Kim KS, Jung YS, Kim DK, Kim J, Cho SJ, Lee IK, Chung J, Kim JS, Choi HS. Int J Mol Sci 24 96 (2022)
  42. Development and pharmacological evaluation of a new chemical series of potent pan-ERR agonists, identification of SLU-PP-915. Hampton CS, Sitaula S, Billon C, Haynes K, Avdagic A, Wanninayake U, Adeyemi CM, Chatterjee A, Griffett K, Banerjee S, Burris SL, Schoepke E, Boehm T, Bess A, de Vera IMS, Burris TP, Walker JK. Eur J Med Chem 258 115582 (2023)
  43. Enantiomer-specific activities of an LRH-1 and SF-1 dual agonist. Mays SG, Stec J, Liu X, D'Agostino EH, Whitby RJ, Ortlund EA. Sci Rep 10 22279 (2020)
  44. Loss of skeletal muscle estrogen-related receptors leads to severe exercise intolerance. Wattez JS, Eury E, Hazen BC, Wade A, Chau S, Ou SC, Russell AP, Cho Y, Kralli A. Mol Metab 68 101670 (2023)
  45. Molecular dynamics of the ERRγ ligand-binding domain bound with agonist and inverse agonist. Sasidharan S, Radhakrishnan K, Lee JY, Saudagar P, Gosu V, Shin D. PLoS One 18 e0283364 (2023)
  46. Three photoinitiators induce breast tumor growth in mouse xenografts with MCF-7 breast cancer cells. Kawasaki Y, Sendo T. Curr Res Toxicol 2 322-328 (2021)


Quick links